XML 50 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary Of Stock-Based Compensation Expense
Stock-based compensation expense is recognized in cost of revenues, corporate, technology and production systems, and selling, general, and administrative expense in the accompanying unaudited condensed consolidated statements of operations and comprehensive income (loss) as follows:
 Three Months Ended
March 31,
 20222023
(in thousands)
Stock-based compensation expense  
Cost of revenues$413 $428 
Corporate technology and production systems531612
Selling, general and administrative4,1647,003
Total stock-based compensation expense$5,108 $8,043 
Share-based Payment Arrangement, Option, Activity
The table below provides a summary of service-based vesting options (“SVOs”) and performance-based stock options (“PSOs”) currently outstanding under the 2015 Plan for the three months ended March 31, 2023:
Outstanding SVOsOutstanding PSOs
Number of
Shares		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Life
(years)		Aggregate
Intrinsic
Value		Number of
Shares		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Life
(years)		Aggregate
Intrinsic
Value
(in thousands, except shares and per share amounts)
Balances as of December 31, 2022
6,208,274 $9.59 5.00$36,513 3,081,855 $10.05 3.32$16,699 
Granted— — — — 
Forfeited / Cancelled— — — — 
Exercised— — — — — — 
Balances as of March 31, 2023 (1)
6,208,274 $9.59 4.72$9,693 3,081,855 $10.05 3.07$3,385 
__________
(1)    All SVOs and PSOs are exercisable as of March 31, 2023.
The table below provides a summary of stock option activity under the 2021 Equity Plan for the three months ended March 31, 2023:

Number of SharesWeighted Average Exercise PriceWeighted Average Contractual Term (in years)Aggregate Intrinsic ValueWeighted Average Fair Value
(per share)
(in thousands, except share and per share amounts)
Outstanding at December 31, 2022
4,387,501 $22.91 8.81$— 
Granted869,874 12.79 $7.07 
Forfeited / Cancelled— — 
Exercised / Released— — — — 
Outstanding at March 31, 2023
5,257,375 $21.23 8.79$— 
Exercisable at March 31, 2023
102,995 $22.61 8.75$— $— 
Share-based Payment Arrangement, Restricted Stock Activity
The table below provides a summary of restricted stock activity under the 2021 Equity Plan for the three months ended March 31, 2023:
Number of SharesWeighted Average Fair Value
(per share)
Unvested at December 31, 2022
3,421,920 $20.32 
Granted1,970,881 12.93 
Forfeited / Cancelled(77,795)21.67 
Vested(92,370)22.35 
Unvested at March 31, 2023
5,222,636 $17.47 
The table below provides a summary of RSU activity under the 2021 Equity Plan for the three months ended March 31, 2023:
Number of SharesWeighted Average Fair Value
(per share)
Unvested at December 31, 2022
51,249 $21.18 
Granted12,262 12.79 
Forfeited / Cancelled(2,254)23.00 
Vested(1,224)22.35 
Unvested at March 31, 2023
60,033 $19.38